FDA blocked publication of COVID, shingles vaccine research findings
A Department of Health and Human Services official says the FDA prevented the release of taxpayer-funded research that found serious vaccine side effects were rare
The Food and Drug Administration (FDA) blocked the publication of several scientific studies that tracked the safety of the COVID-19 and shingles vaccines. According to a spokesperson from the Department of Health and Human Services (HHS), agency scientists conducted the research by analyzing millions of patient records. These internal reviews were designed to monitor the occurrence of adverse events following vaccination.[1][2]
The studies were funded by U.S. taxpayer money and cost several million dollars to complete. Despite the significant investment, the findings remained unpublished. The research specifically examined the safety profiles of the vaccines and concluded that they were safe for public use. The HHS spokesperson confirmed that the data showed serious side effects from the vaccines were rare occurrences.[1]
The decision to withhold the findings has come to light following statements made by the HHS official to ABC News. While the studies reinforced the safety of the vaccines, the FDA's move to block their publication prevented the public and the scientific community from accessing the taxpayer-funded results. The research included extensive analysis of patient data to ensure a comprehensive understanding of vaccine outcomes and safety profiles.[1][2]
